14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.78 $2.84 Friday, 3rd May 2024 REVB stock ended at $2.37. This is 0.85% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.65% from a day low at $2.30 to a day high of $2.43.
90 days $1.78 $4.34
52 weeks $1.78 $39.00

Historical Revelation Biosciences, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $2.38 $2.43 $2.30 $2.37 24 418
May 02, 2024 $2.23 $2.49 $2.16 $2.35 64 242
May 01, 2024 $2.08 $2.23 $2.08 $2.15 27 524
Apr 30, 2024 $2.11 $2.20 $2.10 $2.11 9 721
Apr 29, 2024 $2.20 $2.25 $2.10 $2.12 12 215
Apr 26, 2024 $2.13 $2.30 $2.12 $2.18 45 510
Apr 25, 2024 $2.09 $2.16 $2.03 $2.14 8 423
Apr 24, 2024 $2.14 $2.15 $2.04 $2.09 39 034
Apr 23, 2024 $2.03 $2.19 $2.03 $2.07 27 844
Apr 22, 2024 $2.19 $2.31 $2.02 $2.05 21 567
Apr 19, 2024 $2.30 $2.33 $2.03 $2.24 42 604
Apr 18, 2024 $2.20 $2.38 $2.13 $2.24 92 711
Apr 17, 2024 $1.89 $2.17 $1.88 $2.15 112 331
Apr 16, 2024 $1.88 $1.95 $1.80 $1.91 38 271
Apr 15, 2024 $2.14 $2.23 $1.78 $1.83 92 911
Apr 12, 2024 $2.32 $2.32 $2.05 $2.08 56 395
Apr 11, 2024 $2.36 $2.52 $2.31 $2.32 24 475
Apr 10, 2024 $2.45 $2.49 $2.28 $2.31 49 789
Apr 09, 2024 $2.62 $2.65 $2.43 $2.43 41 796
Apr 08, 2024 $2.70 $2.79 $2.59 $2.60 25 804
Apr 05, 2024 $2.76 $2.84 $2.58 $2.67 31 990
Apr 04, 2024 $2.60 $2.81 $2.60 $2.72 45 781
Apr 03, 2024 $2.55 $2.66 $2.53 $2.60 34 217
Apr 02, 2024 $2.71 $2.71 $2.53 $2.59 68 650
Apr 01, 2024 $2.71 $2.77 $2.60 $2.66 33 488
Click to get the best stock tips daily for free!

About Revelation Biosciences, Inc.

Revelation Biosciences. Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is a... REVB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT